Astellas Bladder Treatment Wins U.S. Approval for Sale

Astellas Pharma Inc. won approval for its overactive bladder treatment aimed at an estimated 33 million Americans who suffer from the condition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.